|Maine Medicine Weekly Update: 12/24/2021
Maine CDC Updates & Guidance
The Maine CDC has transitioned to Pfizer’s gray cap formulation for adults and adolescents (gray cap) as of Friday, December 24.
The CDC has also shut off ordering the Johnson & Johnson COVID-19 vaccine through ImmPact.
They have closed for the 1170 dose Pfizer presentation (purple cap) and transitioning to the new presentation (gray cap) with a 300 minimum dose quantity.
Download the Maine CDC memo on Pfizer’s Gray Cap Formulation and Johnson & Johnson Updates
J&J COVID-19 Vaccine Updates
On Thursday, December 16, the U.S. CDC endorsed updated recommendations made by the Advisory Committee on Immunization Practices (ACIP) for the prevention of COVID-19,expressing a clinical preference for individuals to receive an mRNA COVID-19 vaccine overJohnson & Johnson.
To utilize current inventory levels across Maine, we will be shutting off ordering for the Johnson & Johnson COVID-19 vaccine in ImmPact. This change will be effective Friday,
December 24. For providers who choose to continue vaccinating with the Johnson & Johnson COVID-19 vaccine, an allocation request may be submitted to:
Please contact the Maine Immunization Program with any questions at 207-287-3746 or
< Previous Article | Next Article >
[ return to top ]
ensure delivery of Maine Medicine Weekly Update,
please add 'email@example.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm
For more information or to contact us directly, please visit www.mainemed.com | ©